Dr Reddys Laboratories (RDY) Free Cash Flow (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Free Cash Flow of $26.4 million in the quarter ended Jun 30, 2026, down 89.5% from $251.1 million a year earlier and down 84.6% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Free Cash Flow (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Free Cash Flow came in at $558.47 million as of Jun 30, 2026, down 28.8% year-over-year; for the year ended Mar 31, 2026, it came in at $856 million, down 1.3% from the prior year.
- Annual Free Cash Flow has a five-year compound annual growth rate of 19.2% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Free Cash Flow came in at $867 million in the year ended Mar 31, 2025 (+16.8%), $742 million in the year ended Mar 31, 2024 (+28.4%), $578 million in the year ended Mar 31, 2023 (+226.6%) and $177 million in the year ended Mar 31, 2022 (-50.1%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Free Cash Flow since the quarter ended Jun 30, 2021.
- On a year-over-year basis, Free Cash Flow rose in four of the last eight quarters, with growth averaging 23.4%.
- Peak year-over-year performance for Free Cash Flow in the last five years was growth of 300.1% in the quarter ended Dec 31, 2021, against a decline of 89.5% in the quarter ended Jun 30, 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $171.14 million (quarter ended Mar 31, 2026), $122.47 million (quarter ended Dec 31, 2025) and $238.47 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 6.36 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 5.56 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Dr Reddys Laboratories | 11.01 Bn | 10.38 Bn | 472.93 Mn | 80.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 80.39 Mn |
| Jun 30, 2026 | 26.40 Mn |
| Mar 31, 2026 | -249.76 Mn |
| Dec 31, 2025 | 156.93 Mn |
| Sep 30, 2025 | 238.42 Mn |
| Jun 30, 2025 | 251.10 Mn |
| Sep 30, 2024 | 201.20 Mn |
| Jun 30, 2024 | 163.10 Mn |
| Mar 31, 2024 | -193.17 Mn |
| Dec 31, 2023 | 102.96 Mn |
| Sep 30, 2023 | 261.42 Mn |
| Jun 30, 2023 | 181.22 Mn |
| Mar 31, 2023 | -4.68 Mn |
| Dec 31, 2022 | 318.93 Mn |
| Sep 30, 2022 | 147.90 Mn |
| Jun 30, 2022 | 129.17 Mn |
| Mar 31, 2022 | -218.90 Mn |
| Dec 31, 2021 | 286.54 Mn |
| Sep 30, 2021 | 117.24 Mn |
| Jun 30, 2021 | -3.36 Mn |
API Access
Dr Reddys Laboratories Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();